Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |